版本:
中国

BRIEF-FDA grants Genentech’s tecentriq accelerated approval

April 17 Roche Holding Ag:

* FDA grants Genentech’s tecentriq (atezolizumab) accelerated approval as initial treatment for certain people with advanced bladder cancer

* Genentech - "it is not known if tecentriq is safe and effective in children" Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐